CYP3A4 and cancer: Moreover, quercetin nanoparticles can positively affect the bioavailability of other drugs, like doxorubicin, a cytotoxic drug used in cancer treatment that has poor oral solubility but increases its bioavailability when CYP3A4 and P-gp are inhibited [58].